These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1027634)

  • 1. Systemic and coronary haemodynamic effects of the new hypotensive drug L 6150.
    Maseri A; Pesola A; L'Abbate A; Contini C; Magini G
    J Int Med Res; 1976; 4(6):402-9. PubMed ID: 1027634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of 3-hydrazine-6[N,N-bis(2-hydroxyethyl)-amino]-pyridazine dihydrochloride (L6150) on the general and cardiac haemodynamics of the intact dog.
    Maxwell GM
    Clin Exp Pharmacol Physiol; 1976; 3(4):343-8. PubMed ID: 975622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the hemodynamic effects of single intravenous doses of 3-hydrazino-6-[N,N-bis-(2-hydroxyethyl)-amino]-pyridazine-dihydrochloride and hydralazine.
    De Ponti C; Bardi U; Marchetti M
    Arzneimittelforschung; 1976; 26(11):2089-92. PubMed ID: 1037254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic activity of L 6150. Systemic and coronary circulation.
    Sardi A; Caravaggi AM; Baldoli E
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 279(3):301-12. PubMed ID: 4270747
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihypertensive and antidiuretic effects of 3-hydrazino-6-[N, N-bis (2-hydroxyethyl) amino]-pyridazine (L 6150) in rats.
    Watanabe TX; Shiono K; Saito K; Sokabe H
    Jpn J Pharmacol; 1978 Jun; 28(3):413-22. PubMed ID: 702944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition and metabolism of 3-hydrazino-6-[N,N-bis(2-hydroxyethyl)amino] pyridazine dihydrochloride in man.
    Assandri A; Perazzi A; Buniva G; Pagani V
    Eur J Drug Metab Pharmacokinet; 1979; 4(2):75-82. PubMed ID: 488135
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanism of action of a new hypotensive agent: 3-hydrazino-6-(N,N-bis-(2-hydroxyethyl)-amino)-pyridazine chlorhydrate (L 6150)].
    Baldoli E; Sardi A; Caravaggi AM; Bianchi G
    Boll Chim Farm; 1972 Aug; 111(8):480-8. PubMed ID: 4647088
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic and coronary hemodynamic effects of pinacidil, a new antihypertensive agent, in awake dogs: comparison with hydralazine.
    Kawashima S; Liang CS
    J Pharmacol Exp Ther; 1985 Feb; 232(2):369-75. PubMed ID: 3968638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 3-hydrazino-6[N, N-bis (2-hydroxyethyl) amino]-pyridazine (L 6150) on renin in hypertensive rats.
    Kawashima K; Watanabe TX; Sokabe H
    Jpn J Pharmacol; 1980 Feb; 30(1):116-8. PubMed ID: 6995653
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of a new anti-hypertensive agent (endralazin) upon the general and coronary haemodynamics of the anaesthetized dog.
    Maxwell GM; Ness D; Rencis V
    Eur J Pharmacol; 1981 Feb; 69(4):471-6. PubMed ID: 7250182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic effects of labetalol-induced hypotension in the anaesthetized dog.
    Gustafson C; Ahlgren I; Aronsen KF; Rosberg B
    Br J Anaesth; 1981 Jun; 53(6):585-90. PubMed ID: 7248122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dose-dependent effect of amrinone on hemodynamics, myocardial circulation and myocardial energy requirement. An experimental study].
    Veit S; Brückner JB; Vogt K; Wagner R; Hess W
    Z Kardiol; 1985 Feb; 74(2):76-84. PubMed ID: 3993153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic profile of N-(2,5-dimethyl-1H-pyrrol-1-yl)6-(4-morpholinyl)-3-pyridazinamine hydrochloride in conscious dogs.
    Di Francesco GF; Baldoli E; Marchetti G; Glässer A
    Arzneimittelforschung; 1986; 36(1):84-8. PubMed ID: 3954821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic profile of a new antihypertensive agent D,L-3-[2-(3-t-butylamino-2-hydroxypropoxy)phenyl]-6-hydrazinopyridazine (SK&F 92657).
    Taylor EM; Cameron D; Eden RJ; Fielden R; Owen DA
    J Cardiovasc Pharmacol; 1981; 3(2):337-54. PubMed ID: 6166805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ornipressin (POR 8)--effect on coronary blood circulation and the peripheral circulation. An animal experimental study].
    Veit S; Poethko C; Heidelmeyer CF; Brückner JB
    Anaesthesist; 1993 Sep; 42(9):597-604. PubMed ID: 8214531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of cilazapril on coronary hemodynamics in patients with renovascular hypertension.
    Magrini F; Reggiani P; Fratianni G; Morganti A; Zanchetti A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S128-33. PubMed ID: 1381789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic and coronary hemodynamic effects of pronethalol practolol, sotalol and D-propranolol.
    Rowe GG; Berndt TB; O'Brien GS; Afonso S
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):5-24. PubMed ID: 4404935
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemodynamic profile of the antihypertensive vasodilator cadralazine in conscious dogs.
    Dorigotti L; Ferni G; Lombroso M; Semeraro C
    Arzneimittelforschung; 1984; 34(9):984-7. PubMed ID: 6542375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodynamic mechanism of the hypotensive action of beta-phenyl-GABA esters (phenibut)].
    Tiurenkov IN
    Farmakol Toksikol; 1983; 46(1):54-9. PubMed ID: 6825820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.